Unknown

Dataset Information

0

Validating candidate biomarkers for different stages of non-alcoholic fatty liver disease.


ABSTRACT: Non-alcoholic fatty liver disease (NAFLD) is a common chronic condition caused by the accumulation of fat in the liver. NAFLD may range from simple steatosis to advanced cirrhosis, and affects more than 1 billion people around the world. To date, there has been no effective treatment for NAFLD. In this study, we evaluated the expression of 4 candidate NAFLD biomarkers to assess their possible applicability in the classification and treatment of the disease.Twenty-six obese subjects, who underwent bariatric surgery, were recruited and their liver biopsies obtained. Expression of 4 candidate biomarker genes, PNPLA3, COL1A1, PPP1R3B, and KLF6 were evaluated at gene and protein levels by RT-qPCR and enzyme-linked immunosorbent assay (ELISA), respectively.A significant increase in the levels of COL1A1 protein (P?=?.03) and PNPLA3 protein (P?=?.03) were observed in patients with fibrosis-stage NAFLD compared to that in patients with steatosis-stage NAFLD. However, no significant differences were found in abundance of PPP1R3B and KLF6 proteins or at the gene level for any of the candidate.This is the first study, to our knowledge, to report on the expression levels of candidate biomarker genes for NAFLD in the Saudi population. Although PNPLA3 and PPP1R3B had been previously suggested as biomarkers for steatosis and KLF6 as a possible marker for the fibrosis stage of NAFLD, our results did not support these findings. However, other studies that had linked PNPLA3 to fibrosis in advanced NAFLD supported our current finding of high PNPLA3 protein in patients with fibrosis. Additionally, our results support COL1A1 protein as a potential biomarker for the fibrosis stage of NAFLD, and indicate its use in the screening of patients with NAFLD. Further studies are required to validate the use of COL1A1 as a biomarker for advanced NAFLD in a larger cohort.

SUBMITTER: Al-Qarni R 

PROVIDER: S-EPMC7478685 | biostudies-literature | 2020 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Validating candidate biomarkers for different stages of non-alcoholic fatty liver disease.

Al-Qarni Reem R   Iqbal Muhammad M   Al-Otaibi Maram M   Al-Saif Faisal F   Alfadda Assim A AA   Alkhalidi Hisham H   Bamehriz Fahad F   Hassanain Mazen M  

Medicine 20200901 36


Non-alcoholic fatty liver disease (NAFLD) is a common chronic condition caused by the accumulation of fat in the liver. NAFLD may range from simple steatosis to advanced cirrhosis, and affects more than 1 billion people around the world. To date, there has been no effective treatment for NAFLD. In this study, we evaluated the expression of 4 candidate NAFLD biomarkers to assess their possible applicability in the classification and treatment of the disease.Twenty-six obese subjects, who underwen  ...[more]

Similar Datasets

2014-11-07 | E-GEOD-63067 | biostudies-arrayexpress
2014-11-07 | GSE63067 | GEO
| S-EPMC6334080 | biostudies-literature
| S-EPMC6758911 | biostudies-literature
| S-EPMC10224312 | biostudies-literature
| S-EPMC3040121 | biostudies-literature
| S-EPMC4922334 | biostudies-literature
| S-EPMC4958712 | biostudies-literature
| S-EPMC9204489 | biostudies-literature